このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
IDEAYA Biosciences マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Yujiro Hata
最高経営責任者
US$6.0m
報酬総額
| CEO給与比率 | 10.0% |
| CEO在任期間 | 9yrs |
| CEOの所有権 | 0.9% |
| 経営陣の平均在職期間 | 2.4yrs |
| 取締役会の平均在任期間 | 5.6yrs |
経営陣の近況
Recent updates
Ideaya Biosciences Continues Its Pursuit Of 'Synthetic Lethality'
Jun 18Is IDEAYA Biosciences (NASDAQ:IDYA) A Risky Investment?
Feb 22
Ideaya Biosciences: A Strong Bet In Targeted Oncology
Feb 16Analysts Are Betting On IDEAYA Biosciences, Inc. (NASDAQ:IDYA) With A Big Upgrade This Week
Nov 09Here's Why We're Not Too Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation
Oct 03IDEAYA Biosciences (NASDAQ:IDYA) Is In A Good Position To Deliver On Growth Plans
Jul 04We're Not Very Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Rate
Mar 10Here's Why We're Not Too Worried About IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation
Nov 04Ideaya Biosciences: Prospects Rebound With Updated Uveal Melanoma Data
Oct 06Ideaya Biosciences slides 8.5% aftermarket on $80M stock offering
Sep 14Ideaya wins first milestone in GSK deal as cancer drug reaches clinical trials
Aug 29Analysts Have Just Cut Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Estimates By 6.2%
Aug 25IDEAYA Biosciences GAAP EPS of -$0.57 misses by $0.05, revenue of $11.34M beats by $4.75M
Aug 15IDEAYA, Amgen in clinical trial deal for small molecule cancer agent
Jul 27Ideaya: Next 6 Months Critical For Precision Oncology Biotech
Jun 16Analysts Are Betting On IDEAYA Biosciences, Inc. (NASDAQ:IDYA) With A Big Upgrade This Week
May 16We Think IDEAYA Biosciences (NASDAQ:IDYA) Can Afford To Drive Business Growth
Apr 12IDEAYA Biosciences EPS beats by $0.01, misses on revenue
May 10CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$129m |
| Dec 31 2023 | US$6m | US$598k | -US$113m |
| Sep 30 2023 | n/a | n/a | -US$103m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$68m |
| Dec 31 2022 | US$3m | US$570k | -US$59m |
| Sep 30 2022 | n/a | n/a | -US$53m |
| Jun 30 2022 | n/a | n/a | -US$66m |
| Mar 31 2022 | n/a | n/a | -US$55m |
| Dec 31 2021 | US$4m | US$544k | -US$50m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | -US$31m |
| Dec 31 2020 | US$2m | US$510k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$40m |
| Jun 30 2020 | n/a | n/a | -US$46m |
| Mar 31 2020 | n/a | n/a | -US$44m |
| Dec 31 2019 | US$2m | US$457k | -US$42m |
| Sep 30 2019 | n/a | n/a | -US$40m |
| Jun 30 2019 | n/a | n/a | -US$42m |
| Mar 31 2019 | n/a | n/a | -US$38m |
| Dec 31 2018 | US$2m | US$420k | -US$34m |
報酬と市場: Yujiroの 総報酬 ($USD 6.00M ) は、 US市場 ($USD 6.83M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Yujiroの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Yujiro Hata (50 yo)
9yrs
在職期間
US$5,995,440
報酬
Mr. Yujiro S. Hata serves as an Independent Director at Enanta Pharmaceuticals, Inc. since August 29, 2021. He is a Co-Founder of IDEAYA Biosciences, Inc. and has been its Chief Executive Officer, Presiden...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 9yrs | US$6.00m | 0.90% $ 23.6m | |
| Principal Accounting Officer | 3.4yrs | US$1.41m | 0.032% $ 855.6k | |
| Chief Scientific Officer | 2.6yrs | US$2.76m | 0% $ 0 | |
| Chief Legal Officer & Company Secretary | 4.7yrs | US$1.87m | 0.013% $ 348.7k | |
| Chief Medical Officer | 1.6yrs | US$1.81m | 0% $ 0 | |
| Chief Technology Officer | 1.4yrs | データなし | データなし | |
| Vice President & Head of Human Resources | no data | データなし | データなし | |
| Chief of Staff & Clinical Development | 2.3yrs | データなし | データなし |
2.4yrs
平均在職期間
52yo
平均年齢
経験豊富な経営陣: IDYAの経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 9yrs | US$6.00m | 0.90% $ 23.6m | |
| Independent Director | 4.5yrs | US$358.02k | 0% $ 0 | |
| Independent Director | 8.7yrs | US$363.02k | 0.0057% $ 149.4k | |
| Independent Director | 3.3yrs | US$349.52k | 0% $ 0 | |
| Chair of Scientific Advisory Board | 5.3yrs | データなし | データなし | |
| Independent Director | 5.9yrs | US$364.52k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$350.52k | 0% $ 0 | |
| Member of Scientific Advisory Board | 8.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 5.3yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 8.1yrs | データなし | データなし | |
| Independent Chairman of the Board | 8.4yrs | US$369.52k | 0.022% $ 570.2k | |
| Independent Director | 4yrs | US$349.52k | 0% $ 0 |
5.6yrs
平均在職期間
67.5yo
平均年齢
経験豊富なボード: IDYAの 取締役会 は 経験豊富 であると考えられます ( 5.6年の平均在任期間)。